| Full Name | Brett Erdreich |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 10 Years |
| Location | 130 Fisher Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053725200 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vassar Brothers Medical Center | Poughkeepsie, NY | Hospital |
| Northern Dutchess Hospital | Rhinebeck, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice, Pc | 1658468442 | 441 |
News Archive
Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer cells into responding to new treatments and undergoing cell suicide.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
A new study conducted by researchers at the University of Cordoba links moderate physical activity in males with better hormone levels and sperm characteristics that favour reproduction compared to sedentary men.
The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy, report an international team of researchers led by investigators at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.
› Verified 5 days ago
| Entity Name | Nuvance Health Medical Practice, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437358033 PECOS PAC ID: 1658468442 Enrollment ID: O20071025000436 |
News Archive
Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer cells into responding to new treatments and undergoing cell suicide.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
A new study conducted by researchers at the University of Cordoba links moderate physical activity in males with better hormone levels and sperm characteristics that favour reproduction compared to sedentary men.
The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy, report an international team of researchers led by investigators at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brett Erdreich, 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-2700 | Brett Erdreich, 130 Fisher Rd, Berlin, VT 05602 Ph: (802) 371-4100 |
News Archive
Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer cells into responding to new treatments and undergoing cell suicide.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
A new study conducted by researchers at the University of Cordoba links moderate physical activity in males with better hormone levels and sperm characteristics that favour reproduction compared to sedentary men.
The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy, report an international team of researchers led by investigators at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.
› Verified 5 days ago
Laura Allen Felsted, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Ste 3, Mountainview Medical, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Devika Singh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Mob-b Suite 3, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Dr. Joachim Georg Mueller, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Cardiology Mob-a Suite 2-1, Berlin, VT 05602 Phone: 802-225-5660 Fax: 802-229-9533 | |
Sarah E Swift, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Hannah Swayze-quinn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Peter Alan Redford, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 |